Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Lord

Showing results (91-100 of 222) with videos related to

Pageof 23
Sort By:
Plos One|February 17, 2016
CDK1 Is a Synthetic Lethal Target for KRAS Mutant TumoursSara Costa-Cabral, Rachel Brough, Asha Konde, et al.
Plos One|April 21, 2017
Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant TumoursSara Costa-Cabral, Rachel Brough, Asha Konde, et al.
Plos One|October 27, 2018
Correction: Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant TumoursSara Costa-Cabral, Rachel Brough, Asha Konde, et al.
Plos One|April 19, 2016
Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant TumoursSara Costa-Cabral, Rachel Brough, Asha Konde, et al.
EMBO Molecular Medicine|January 6, 2010
Synthetic lethal targeting of PTEN mutant cells with PARP inhibitorsAna M Mendes-Pereira, Sarah A Martin, Rachel Brough, et al.
Nature Genetics|March 3, 2025
The transcriptomic architecture of common cancers reflects synthetic lethal interactionsSyed Haider, Rachel Brough, Santiago Madera, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 13, 2011
Genome-wide functional screen identifies a compendium of genes affecting sensitivity to tamoxifenAna M Mendes-Pereira, David Sims, Tim Dexter, et al.
Nucleic Acids Research|May 15, 2014
Genome-wide characterization reveals complex interplay between TP53 and TP63 in response to genotoxic stressSimon S McDade, Daksha Patel, Michael Moran, et al.
Plos One|July 14, 2011
Comprehensive genomic analysis of a BRCA2 deficient human pancreatic cancerLouise J Barber, Juan M Rosa Rosa, Iwanka Kozarewa, et al.
Cancer Discovery|July 24, 2020
Clinical <i>BRCA1/2</i> Reversion Analysis Identifies Hotspot Mutations and Predicted Neoantigens Associated with Therapy ResistanceStephen J Pettitt, Jessica R Frankum, Marco Punta, et al.
Pageof 23

Showing results (91-100 of 222) with videos related to

Sort By:
Pageof 23
Plos One|February 17, 2016
CDK1 Is a Synthetic Lethal Target for KRAS Mutant TumoursSara Costa-Cabral, Rachel Brough, Asha Konde, et al.
Plos One|April 21, 2017
Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant TumoursSara Costa-Cabral, Rachel Brough, Asha Konde, et al.
Plos One|October 27, 2018
Correction: Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant TumoursSara Costa-Cabral, Rachel Brough, Asha Konde, et al.
Plos One|April 19, 2016
Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant TumoursSara Costa-Cabral, Rachel Brough, Asha Konde, et al.
EMBO Molecular Medicine|January 6, 2010
Synthetic lethal targeting of PTEN mutant cells with PARP inhibitorsAna M Mendes-Pereira, Sarah A Martin, Rachel Brough, et al.
Nature Genetics|March 3, 2025
The transcriptomic architecture of common cancers reflects synthetic lethal interactionsSyed Haider, Rachel Brough, Santiago Madera, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 13, 2011
Genome-wide functional screen identifies a compendium of genes affecting sensitivity to tamoxifenAna M Mendes-Pereira, David Sims, Tim Dexter, et al.
Nucleic Acids Research|May 15, 2014
Genome-wide characterization reveals complex interplay between TP53 and TP63 in response to genotoxic stressSimon S McDade, Daksha Patel, Michael Moran, et al.
Plos One|July 14, 2011
Comprehensive genomic analysis of a BRCA2 deficient human pancreatic cancerLouise J Barber, Juan M Rosa Rosa, Iwanka Kozarewa, et al.
Cancer Discovery|July 24, 2020
Clinical <i>BRCA1/2</i> Reversion Analysis Identifies Hotspot Mutations and Predicted Neoantigens Associated with Therapy ResistanceStephen J Pettitt, Jessica R Frankum, Marco Punta, et al.
Pageof 23